Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
City of Hope Medical Center
Takeda
Universität des Saarlandes
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
BeiGene
Takeda
Stanford University
Children's Oncology Group
University of Nebraska
University of Nebraska
City of Hope Medical Center
Seagen Inc.
University of Nebraska
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Seagen Inc.
Takeda
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Takeda
Masonic Cancer Center, University of Minnesota
Mayo Clinic
M.D. Anderson Cancer Center
Takeda
Children's Oncology Group
Novartis
National Cancer Institute (NCI)
Mayo Clinic
Fred Hutchinson Cancer Center
Novartis
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Mayo Clinic
University of Chicago
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Case Comprehensive Cancer Center
Wake Forest University Health Sciences
University of Arizona
National Cancer Institute (NCI)